Steris Corp. Company Profile (NYSE:STE)

About Steris Corp.

Steris Corp. logoSTERIS Corporation (STERIS) is a provider of infection prevention and other procedural products and services. The Company is focused on healthcare, pharmaceutical and research. The Company operates through three business segments: Healthcare, Life Sciences and STERIS Isomedix Services. The Healthcare segment provides surgical, sterile processing, infection prevention and gastrointestinal solutions. It offers support to the operating room, as well as to the sterile processing functions where instruments are reprocessed between surgeries and gastrointestinal procedures. The Life Sciences segment serves the pharmaceutical manufacturers and research organizations by providing decontamination and sterilization technologies, products and services. The Isomedix segment provides ethylene oxide and gamma irradiation services on a contract basis through a network of facilities in North America, where STERIS processes medical devices and other products.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Medical Appliances & Equipment
  • Sub-Industry: Health Care Equipment
  • Exchange: NYSE
  • Symbol: STE
  • CUSIP: 85915210
Key Metrics:
  • Previous Close: $73.12
  • 50 Day Moving Average: $71.23
  • 200 Day Moving Average: $70.13
  • 52-Week Range: $61.38 - $78.77
  • Trailing P/E Ratio: 42.00
  • Foreward P/E Ratio: 16.73
  • P/E Growth: 1.90
  • Market Cap: $6.30B
  • Outstanding Shares: 86,148,000
  • Beta: 1.16
  • Net Margins: 5.52%
  • Return on Equity: 10.72%
  • Return on Assets: 5.96%
  • Debt-to-Equity Ratio: 0.51%
  • Current Ratio: 2.63%
  • Quick Ratio: 2.05%
Additional Links:
Companies Related to Steris Corp.:

Analyst Ratings

Consensus Ratings for Steris Corp. (NYSE:STE) (?)
Ratings Breakdown: 2 Buy Ratings
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $83.00 (13.51% upside)

Analysts' Ratings History for Steris Corp. (NYSE:STE)
DateFirmActionRatingPrice TargetDetails
6/3/2016Northcoast ResearchUpgradeNeutral -> BuyView Rating Details
11/2/2015Raymond James Financial Inc.Boost Price Target$74.00 -> $82.00View Rating Details
11/2/2015JMP SecuritiesBoost Price TargetMarket Outperform$74.00 -> $84.00View Rating Details
6/2/2015Bank of America Corp.Reiterated RatingBuy$75.00 -> $72.00View Rating Details
(Data available from 9/28/2014 forward)


Earnings History for Steris Corp. (NYSE:STE)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
8/9/2016Q117$0.77$0.79$639.04 million$638.40 millionViewListenView Earnings Details
5/18/2016Q416$1.04$0.90$701.92 million$690.30 millionViewListenView Earnings Details
2/9/2016Q316$0.94$0.98$617.35 million$618.70 millionViewN/AView Earnings Details
10/30/2015Q216$0.76$0.83$488.66 million$489.90 millionViewListenView Earnings Details
8/4/2015Q415$0.61$0.62$439.23 million$439.90 millionViewListenView Earnings Details
5/7/2015Q4$0.89$0.98$520.07 million$501.60 millionViewListenView Earnings Details
2/4/2015Q315$0.73$0.79$475.22 million$473.20 millionViewListenView Earnings Details
11/4/2014Q215$0.62$0.68$452.50 million$462.70 millionViewListenView Earnings Details
8/5/2014Q115$0.54$0.54$418.26 million$412.60 millionViewListenView Earnings Details
5/8/2014Q4$0.86$0.91$455.92 million$465.30 millionViewListenView Earnings Details
2/5/2014Q314$0.69$0.59$406.40 million$405.60 millionViewListenView Earnings Details
10/30/2013Q214$0.54$0.55$376.82 million$383.80 millionViewListenView Earnings Details
8/7/2013Q1 2014$0.56$0.44$372.69 million$367.70 millionViewListenView Earnings Details
5/7/2013Q4 2013$0.65$0.70$405.79 million$426.20 millionViewListenView Earnings Details
2/6/2013Q3 2013$0.56$0.58$368.84 million$380.40 millionViewListenView Earnings Details
10/31/2012Q213$0.52$0.53$350.23 million$356.30 millionViewN/AView Earnings Details
8/2/2012$0.44$0.53ViewN/AView Earnings Details
5/8/2012$0.60$0.59ViewN/AView Earnings Details
2/7/2012$0.60$0.58ViewN/AView Earnings Details
11/2/2011$0.57$0.50ViewN/AView Earnings Details
8/2/2011$0.50$0.46ViewN/AView Earnings Details
5/9/2011$0.62$0.61ViewN/AView Earnings Details
2/8/2011$0.58$0.57ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for Steris Corp. (NYSE:STE)
Current Year EPS Consensus Estimate: $3.90 EPS
Next Year EPS Consensus Estimate: $4.37 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20164$1.03$1.20$1.09
Q2 20162$0.80$0.82$0.81
Q3 20163$0.90$0.94$0.92
Q4 20162$1.06$1.07$1.07
Q1 20172$0.75$0.80$0.78
Q2 20172$0.88$0.93$0.91
Q3 20172$1.04$1.05$1.05
Q4 20172$1.16$1.17$1.17
Q1 20181$0.95$0.95$0.95
Q2 20181$1.07$1.07$1.07
Q3 20181$1.19$1.19$1.19
Q4 20181$1.33$1.33$1.33
(Data provided by Zacks Investment Research)


Current Dividend Information for Steris Corp. (NYSE:STE)
Annual Dividend:$1.12
Dividend Yield:1.53%
Dividend Growth:10.10% (3 Year Average)
Payout Ratio:68.71% (Based on Trailing 12 Months of Earnings)
28.72% (Based on Current Year Consensus EPS Estimate)
25.63% (Based on Next Year Consensus EPS Estimate)
Track Record:6 Years of Consecutive Dividend Growth

Dividend History for Steris Corp. (NYSE:STE)
AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
(Data available from 1/1/2013 forward)

Insider Trades

Insider Trading History for Steris Corp. (NYSE:STE)
Insider Ownership Percentage: 2.52%
Institutional Ownership Percentage: 91.58%
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
9/7/2016Richard Martin SteevesDirectorSell204,778$71.19$14,578,145.82View SEC Filing  
8/31/2016Adrian Vincent CowardInsiderSell15,000$69.00$1,035,000.00View SEC Filing  
8/26/2016Sudhir K. PahwaVPSell1,028$70.13$72,093.64View SEC Filing  
8/17/2016Walter M. Rosebrough, Jr.CEOSell15,000$71.08$1,066,200.00View SEC Filing  
8/12/2016Daniel A. CarestioInsiderSell2,681$71.04$190,458.24View SEC Filing  
2/17/2016Walter M. Rosebrough, Jr.CEOSell10,000$64.27$642,700.00View SEC Filing  
11/18/2015Walter M Rosebrough JrCEOSell11,960$75.58$903,936.80View SEC Filing  
11/9/2015Kathleen BardwellinsiderSell2,496$73.85$184,329.60View SEC Filing  
11/9/2015Kevin M. McmullenDirectorSell8,000$73.73$589,840.00View SEC Filing  
11/3/2015Mohsen SohiDirectorSell3,000$76.36$229,080.00View SEC Filing  
10/30/2015Daniel A. CarestioinsiderSell6,270$74.00$463,980.00View SEC Filing  
10/28/2015Sudhir K PahwaVPSell1,000$70.09$70,090.00View SEC Filing  
9/30/2015Walter M Rosebrough JrCEOSell5,000$64.92$324,600.00View SEC Filing  
9/29/2015Walter M Rosebrough JrCEOSell10,000$64.43$644,300.00View SEC Filing  
6/15/2015David Allen JohnsonVPSell1,826$63.08$115,184.08View SEC Filing  
6/10/2015Walter M Rosebrough JrCEOSell20,000$63.80$1,276,000.00View SEC Filing  
6/9/2015Walter M Rosebrough JrCEOSell5,000$63.56$317,800.00View SEC Filing  
8/11/2014Michael B WoodDirectorSell5,300$51.79$274,487.00View SEC Filing  
6/2/2014John Adam ZangerleVPSell2,000$53.45$106,900.00View SEC Filing  
5/12/2014John WarehamDirectorSell15,000$55.09$826,350.00View SEC Filing  
4/2/2014Michael TokichCFOSell4,525$51.68$233,852.00View SEC Filing  
1/8/2014Michael TokichCFOSell4,200$48.72$204,624.00View SEC Filing  
11/26/2013Cynthia FeldmannDirectorSell6,254$45.97$287,496.38View SEC Filing  
8/8/2013Timothy ChapmanSVPSell10,000$43.84$438,400.00View SEC Filing  
6/12/2013Kevin M McmullenDirectorSell10,000$44.09$440,900.00View SEC Filing  
5/30/2013Walter M Rosebrough JrCEOSell2,000$45.72$91,440.00View SEC Filing  
5/22/2013Mohsen SohiDirectorSell10,000$45.21$452,100.00View SEC Filing  
5/21/2013William L AamothTreasurerSell6,150$45.96$282,654.00View SEC Filing  
5/13/2013David Allen JohnsonVPSell2,680$44.99$120,573.20View SEC Filing  
10/5/2012Michael J TokichCFOSell4,100$37.00$151,700.00View SEC Filing  
8/9/2012Cynthia L FeldmannDirectorSell23,122$34.05$787,304.10View SEC Filing  
(Data available from 1/1/2013 forward)


Latest Headlines for Steris Corp. (NYSE:STE)
DateHeadline logoInfection Control (Disinfection & Sterilization) Global Market - Forecast to 2022 (NYSE:STE) - September 26 at 7:32 PM logoRisk assessments in fungal spore and bacterial spore excursions (NYSE:STE) - September 26 at 7:32 PM
News IconWhat is the Street Saying About STERIS Corporation (NYSE:STE)? - Frisco Fastball (NYSE:STE) - September 25 at 5:58 PM
News IconIQ4I Research & Consultancy Published a New Report on “Infection Control Global Market – Forecast To 2022” (NYSE:STE) - September 25 at 11:36 AM
News IconFortis Institute seeks zoning variance to relocate in Millcreek (NYSE:STE) - September 25 at 11:36 AM logoGlobal Infection Control Market Is Expected to Reach $22,582 Million by 2022; Finds New Report (NYSE:STE) - September 23 at 6:53 PM
News IconSteering Attention Towards Earnings; Analysts Weigh in on STERIS Corporation (NYSE:STE) Stock - Frisco Fastball (NYSE:STE) - September 23 at 11:17 AM logoSTERIS Corporation (NYSE:STE)'s Accounts Payable Is $123.253 - (NYSE:STE) - September 23 at 11:17 AM logoStocks Higher As S&P 500 Reaches Key Level, Amazon Hits New High (NYSE:STE) - September 22 at 7:07 PM logoInfection Control (Disinfection & Sterilization) Market 2016 Analysis and Forecast to 2022 (NYSE:STE) - September 22 at 11:29 AM logoSTEWART & WIGHT PLC : ex-dividend day for final dividend (NYSE:STE) - September 22 at 11:29 AM
News IconTeam building workshop offered at Edison (NYSE:STE) - September 21 at 11:37 AM
News IconQ1 2017 EPS Estimates for STERIS Corp (STE) Increased by Analyst - DailyQuint (NYSE:STE) - September 20 at 10:41 AM logoSTERIS Corporation (NYSE:STE) Makes Public Its Dividend Alert Of $0.28 - Stocks Daily (NYSE:STE) - September 19 at 7:27 PM
News IconErie needs leaders focused on economic growth: Letters to the editor (NYSE:STE) - September 17 at 11:20 AM logoSterilization Technologies Market Share to Reach $6.7 billion with 5.8% CAGR Forecast to 2022 (NYSE:STE) - September 16 at 7:12 PM logoSTERIS Plc – Value Analysis (NYSE:STE) : September 15, 2016 (NYSE:STE) - September 15 at 7:36 PM logoSTERIS Plc breached its 50 day moving average in a Bearish Manner : STE-US : September 14, 2016 (NYSE:STE) - September 14 at 11:50 AM logoMedical Disposables Market 2016 Global Trends, Market Share, Industry Size, Growth, Opportunities, and Forecast to 2022 (NYSE:STE) - September 9 at 11:20 AM logoAgenda released for the highly anticipated 6th annual Pharmaceutical Microbiology event: Join MHRA, Merial SAS, Pfizer, GSK, Sanofi and many more (NYSE:STE) - September 8 at 11:22 AM logoSTERIS Poised on Synergy Health Addition amid Currency Woes (NYSE:STE) - September 8 at 11:22 AM logoHPV Decontamination Systems Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2016 - 2024 (NYSE:STE) - September 7 at 7:37 PM
News IconSC Johnson acquires STERIS AIC business (NYSE:STE) - September 6 at 7:37 PM
News IconGlobal Markets for Controlled Intelligent Packaging, Preservation and Shelf-Life Extension for Food and Beverages (NYSE:STE) - September 6 at 11:16 AM
News IconOperating room equipment market 2016 - industry trends, review, research and forecast analysis detailed in new research report (NYSE:STE) - September 6 at 11:16 AM
News IconFDA bans chemicals used in antibacterial soaps (NYSE:STE) - September 4 at 11:24 AM
News IconFDA is cracking down on antibacterial hand soap! (NYSE:STE) - September 3 at 6:34 PM
News IconFDA bans some antibacterial soaps, body washes (NYSE:STE) - September 3 at 10:58 AM
News IconGlobal Surface Disinfectant Sales Market Report 2021 is released (NYSE:STE) - September 3 at 10:58 AM
News IconFDA halts sale of some antibacterial OTC hand, body wash products (NYSE:STE) - September 2 at 7:22 PM logoS.C. Johnson buys infection control business of U.K.'s Steris (NYSE:STE) - September 2 at 7:22 PM
News IconSC Johnson buys infection-control business (NYSE:STE) - September 2 at 12:24 PM
News IconSCJ Acquisition To Help Deb's Hospital Presence (NYSE:STE) - September 2 at 12:24 PM logoUPDATE 1-FDA halts sale of some antibacterial OTC hand, body wash products (NYSE:STE) - September 2 at 12:24 PM
News IconSC Johnson acquires infection control business (NYSE:STE) - September 2 at 12:24 PM logoSC Johnson Announces Acquisition of STERIS Applied Infection Control Business (NYSE:STE) - September 1 at 7:29 PM logoSTERIS Plc : STE-US: Dividend Analysis : August 30th, 2016 (record date) : By the numbers : September 1, 2016 (NYSE:STE) - September 1 at 7:28 PM logoSTERIS PLC Files SEC form 8-K, Regulation FD Disclosure (NYSE:STE) - September 1 at 7:28 PM
News IconIncreasing Number Of Healthcare Facilities To Boost U.S. Hospital Supplies Market (NYSE:STE) - September 1 at 10:41 AM
News IconIn Cleveland, Lawyers See Steady Growth Ahead (NYSE:STE) - August 30 at 7:25 PM logo[$$] 3 Small-Cap Stocks Worth Buying Now (NYSE:STE) - August 26 at 10:30 AM
News IconResearch Background & Research Ideas : Asia-Pacific Operating Room Equipment Market Outlook to 2021 (NYSE:STE) - August 25 at 7:49 PM logoGlobal Sterilization Equipment and Supplie Industry (NYSE:STE) - August 25 at 7:49 PM logoSTERIS Corporation (NYSE:STE) Gets 0 Recommendations To Sell - Investor Newswire (NYSE:STE) - August 25 at 11:40 AM logoSTERIS Plc breached its 50 day moving average in a Bearish Manner : STE-US : August 25, 2016 (NYSE:STE) - August 25 at 11:40 AM logoSteris : Medical Equipment Stocks Technical Reports -- St. Jude Medical, Wright Medical, Edwards Lifesciences, and Steris (NYSE:STE) - August 23 at 12:09 PM
News IconCrowd & Street Views on STERIS Corporation (NYSE:STE) - Post News (NYSE:STE) - August 22 at 7:31 PM logoHybrid Operating Room Market 2016 Market Share, competitor Strategy and Future Forecast to 2027. (NYSE:STE) - August 19 at 7:29 PM logoInsiders Selling, Short Interest Growing STERIS plc Ordinary Shares (NYSE:STE) (NYSE:STE) - August 19 at 7:29 PM logoSTERIS PLC Financials (NYSE:STE) - August 18 at 7:51 PM


Steris Corp. (NYSE:STE) Chart for Wednesday, September, 28, 2016

Last Updated on 9/28/2016 by Staff